You have read all your free articles, to continue reading subscribe to read the rest of this content.
Gesynta Pharma has successfully raised SEK 190 million in one of the largest private biotech placements of the year in the Nordics. The placement was led by European life science fund manager Hadean Ventures, joined by existing investor Industrifonden and private funds. “We believe mPGES-1 iAlready a subscriber Login You…
Swedish Orphan Biovitrum (Sobi) and Apellis Pharmaceuticals have announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion recommending the marketing authorisation of Aspaveli (pegcetacoplan) for the treatment of adultsAlready a subscriber Login You have read all your free…
Affibosy's partner Biotest, a Germany-based biotherapeutic company, has exercised an option under the two companies’ ongoing collaboration. “Biotest has finalized the research phase of the research license and option agreement we originally signed in 2015 and based on the preclinical results Already a subscriber Login You have read all your…
Oasmia Pharmaceutical AB has announced that it will launch their product Paclical in Russia and the Commonwealth of Independent States (CIS) countries. Oasmia Pharmaceutical, a developer of a new generation of drugs within human and veterinary oncology, has announced that it has shipped PaclicalAlready a subscriber Login You have read all…
